辉瑞+惠氏=?

辉瑞和惠氏在业务领域、研发能力等方面具有较强互补性,二者的合并有助于辉瑞在短期内拓展业务空间,提升盈利水平,但有人也担心,长期下来,这种壮大模式会缺乏持续能动力。

Pfizer and Wyeth have complementary business fields and research abilities, and the acquisition will help Pfizer expand its business space and increase its profit in a short term. But for the long term, there is much concern about whether this pattern lacks sustainable drive for development.